Deranged Wnt signaling is frequent in hereditary nonpolyposis colorectal cancer

被引:4
作者
Isinger-Ekstrand, Anna [1 ,2 ]
Therkildsen, Christina [3 ]
Bernstein, Inge [4 ]
Nilbert, Mef [1 ,2 ,3 ]
机构
[1] Skane Univ Hosp, Dept Oncol, S-22185 Lund, Sweden
[2] Lund Univ, Dept Oncol, Inst Clin Sci, Lund, Sweden
[3] Univ Copenhagen, Clin Res Ctr, Hvidovre Hosp, Copenhagen, Denmark
[4] Univ Copenhagen, HNPCC Register, Hvidovre Hosp, Copenhagen, Denmark
基金
英国医学研究理事会;
关键词
beta-catenin; E-cadherin; HNPCC; Lynch syndrome; PTEN; TCF-4; Wnt signaling; BETA-CATENIN; MUTATIONS; APC; CARCINOMAS; PATHWAY; EXPRESSION; TUMORS; GENE;
D O I
10.1007/s10689-010-9406-x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The Wnt signaling pathway is frequently deranged in colorectal cancer and is a key target for future preventive and therapeutic approaches. Colorectal cancers associated with the hereditary nonpolyposis colorectal cancer (HNPCC) syndrome are characterized by wide-spread microsatellite instability, but show few gross genomic alterations. We characterized expression of the Wnt signaling pathway markers beta-catenin, E-cadherin, TCF-4, and PTEN using immunohistochemical staining in colorectal cancers from individuals with HNPCC. Reduced membranous staining for beta-catenin was found in 64% and for E-cadherin in 80% with strong correlation between these markers (P = 0.001). Nuclear beta-catenin staining was detected in 19% of the tumors. Overexpression of TCF-4, which is activated by beta-catenin, was found in 89% and downregulation of PTEN, which suppresses nuclear accumulation of beta-catenin, was present in 54% of the tumors. In summary, altered expression of target molecules in the Wnt signaling pathway was demonstrated in the vast majority of the HNPCC-associated tumors, which support deranged Wnt-signaling as a central tumorigenic mechanism also in MMR defective colorectal cancer.
引用
收藏
页码:239 / 243
页数:5
相关论文
共 21 条
[1]  
Duval A, 1999, CANCER RES, V59, P4213
[2]  
Duval A, 2000, CANCER RES, V60, P3872
[3]   Frequent alterations of the PI3K/AKT/mTOR pathways in hereditary nonpolyposis colorectal cancer [J].
Ekstrand, Anna Isinger ;
Jonsson, Mats ;
Lindblom, Annika ;
Borg, Ake ;
Nilbert, Mef .
FAMILIAL CANCER, 2010, 9 (02) :125-129
[4]  
Gafà R, 2000, CANCER, V89, P2025, DOI 10.1002/1097-0142(20001115)89:10<2025::AID-CNCR1>3.0.CO
[5]  
2-S
[6]   Phenotypic heterogeneity in hereditary non-polyposis colorectal cancer:: identical germline mutations associated with variable tumour morphology and immunohistochemical expression [J].
Halvarsson, Britta ;
Mueller, Wolfram ;
Planck, Maria ;
Benoni, Anna Clara ;
Mangell, Peter ;
Ottosson, Johan ;
Hallen, Magnus ;
Isinger, Anna ;
Nilbert, Mef .
JOURNAL OF CLINICAL PATHOLOGY, 2007, 60 (07) :781-786
[7]   β-catenin–sensitive isoforms of lymphoid enhancer factor-1 are selectively expressed in colon cancer [J].
Karine Hovanes ;
Tony W.H. Li ;
Jesus E. Munguia ;
Trung Truong ;
Tatjana Milovanovic ;
J. Lawrence Marsh ;
Randall F. Holcombe ;
Marian L. Waterman .
Nature Genetics, 2001, 28 (1) :53-57
[8]   Classification of colorectal cancer based on correlation of clinical, morphological and molecular features [J].
Jass, J. R. .
HISTOPATHOLOGY, 2007, 50 (01) :113-130
[9]   Exon 3 β-catenin mutations are specifically associated with colorectal carcinomas in hereditary non-polyposis colorectal cancer syndrome [J].
Johnson, V ;
Volikos, E ;
Halford, SE ;
Sadat, ETE ;
Popat, S ;
Talbot, I ;
Truninger, K ;
Martin, J ;
Jass, J ;
Houlston, R ;
Atkin, W ;
Tomlinson, IPM ;
Silver, ARJ .
GUT, 2005, 54 (02) :264-267
[10]   APC and β-catenin protein expression patterns in HNPCC-related endometrial and colorectal cancers [J].
Kariola, R ;
Abdel-Rahman, WM ;
Ollikainen, M ;
Butzow, R ;
Peltomäki, P ;
Nyström, M .
FAMILIAL CANCER, 2005, 4 (02) :187-190